The FDA announced today that the CDC PCR test for COVID-19 has failed its full review…
After December 31, 2021, CDC will withdraw the request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2 only. CDC is providing this advance notice for clinical laboratories to have adequate time to select and implement one of the many FDA-authorized alternatives.
In preparation for this change, CDC recommends clinical laboratories and testing sites that have been using the CDC 2019-nCoV RT-PCR assay select and begin their transition to another FDA-authorized COVID-19 test. CDC encourages laboratories to consider adoption of a multiplexed method that can facilitate detection and differentiation of SARS-CoV-2 and influenza viruses.
Such assays can facilitate continued testing for both influenza and SARS-CoV-2 and can save both time and resources as we head into influenza season. Laboratories and testing sites should validate and verify their selected assay within their facility before beginning clinical testing.
According to the inventor Mullis, “PCR cannot be totally and should never be used as a tool in “the diagnosis of infectious diseases.”
Flashback: Fauci says any positive test above 35 cycles is a false postive.
CDC Test Change Reveals They Were NEVER Testing for COVID-19
The fraud is worse than the magnification factor. FDA can’t even compare effectiveness of the tests since the 59 tests were looking for different things. Some were looking for synthetic RNA, some for gene specific RNA, some for whole genome RNA. CDC says that since they didn’t have a sample, they used “contrived samples”.
Censorship has caused support for our fundraising campaign to drop drastically. If you like what we do then please help us to keep doing it by supporting us today.